Olezarsen reduces all-cause health services utilization and improves the treatment experience of patients with familial chylomicronemia syndrome

Authors:

Abstract
No abstract available
Funding Information
  • Ionis Pharmaceuticals

This publication has 24 references indexed in Scilit: